CytoCore, Inc (CYOE.OB) announced that the company has recently appointed EVC Group, Inc. as their agency of record. EVC Group will be responsible for investor relations, corporate communications, and trade media relations. The firm will create and implement a proactive program designed to build awareness amongst investors and other targeted audiences.
Robert McCullough, CEO of CytoCore, stated, “As CytoCore expands its European launch of the SoftPAP(TM) cell collector, and plans a U.S. launch within the next 90 days, it is important for our Company to continuously communicate our progress against plan as well as to expand our awareness with potential customers and investors.”
McCullough added, “EVC Group is a business communications firm dedicated to serving small cap companies. Importantly, the firm has extensive experience in the healthcare field. In addition, EVC Group has a proven track record for generating new interest among actionable investors for their clients as well as impressive media relations capabilities. We look forward to working with the EVC team to increase public awareness and understanding of CytoCore.”
EVC Group, Inc. is headquartered in San Francisco and has multiple offices in New York City. The firm currently serves a select number of emerging growth companies in the health care, technology, consumer goods, mining, financial services and business services industries.
Let us hear your thoughts below: